US5470307A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Catheter system for controllably releasing a therapeutic agent at a remote tissue site
Assignee: Individual
•
Filing: 1994-03-16
•
Granted: 1995-11-28
•
Expires: 2014-03-16
Abstract
Abstract A catheter having a therapeutic agent chemically bonded to a substrate on its exterior surface using a linker which photolytically releases the agent upon exposure to light energy at an appropriate wavelength. The linker is attached to the substrate via a complementary chemical group, with the opposing end containing an aromatic ring with a nitro group in the ortho position relative to a methyl or ethyl group which is functionalized to accept a complementary bond to the therapeutic agent. The substrate may include materials such as glass, polyamide, polyester, polyolefin, polypropylene, polyurethane, or latex. The therapeutic agent may include peptides, proteins, steroids, carbohydrates, nucleotides, or other aliphatic or heterocyclic products, and may be bonded to a molecular lattice or meshwork to accommodate a high molecular concentration per unit area and the inclusion of ancillary compounds such as markers or secondary emitters.
Inventors
- 👤 Arnold W. Lindall
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 00:54
CPC Classifications
A; A61; A61N; A61N5/00; A61N5/06; A61N5/0613; A61N5/062; A61L; A61L29/00; A61L29/14; A61L29/16; A61N5/0601; A61L2300/00; A61L2300/20; A61L2300/22; A61L2300/222; A61L2300/23; A61L2300/25; A61L2300/252; A61L2300/258; A61L2300/60; A61L2300/602; A61M; A61M25/00; A61M25/0043; A61M2025/0057
Claims Analysis
Total Claims: 26
Claim 1
Independent Claim
113 words
A catheter for applying a therapeutic agent to a tissue site by selectively releasing said therapeutic agent in response to light energy emanating from a source and conducted through at least a portion of said catheter, said catheter comprising: a catheter body, said catheter body having a surface including a substrate layer; and a linker layer, said linker layer being chemically bonded to said substrate layer with the therapeutic agent being chemically bonded to said linker layer, the therapeutic agent being selectively released from said substrate layer by a photolytic chemical reaction occurring in response to exposure to the light energy emanating from the source and conducted through the portion of the catheter.
Claim 2
Dependent Claim
113 words
A catheter for applying a therapeutic agent to a tissue site by selectively releasing said therapeutic agent in response to light energy emanating from a source and conducted through at least a portion of said catheter, said catheter comprising: a catheter body, said catheter body having a surface including a substrate layer; and a linker layer, said linker layer being chemically bonded to said substrate layer with the therapeutic agent being chemically bonded to said linker layer, the therapeutic agent being selectively released from said substrate layer by a photolytic chemical reaction occurring in response to exposure to the light energy emanating from the source and conducted through the portion of the catheter.
Claim 3
Dependent Claim
80 words
The catheter of claim 1 wherein the catheter body is a conventional medical catheter selected from the group including: a percutaneous transluminal angiography (PTA) catheter, a percutaneous transluminal coronary angioplasty (PTCA) catheter, a vascular catheter, a peripheral vascular catheter, a thrombectomy catheter, an embolectomy catheter, a renal catheter, a esophageal catheter, a perfusion catheter, an upper gastrointestinal catheter, a lower gastrointestinal catheter, a bile duct catheter, a pancreatic duct catheter, a urethral catheter, a ureteral catheter, and a urogenital catheter.
Claim 4
Dependent Claim
14 words
The catheter of claim 1 wherein the catheter body is a fiber optic probe.
Claim 5
Dependent Claim
14 words
The catheter of claim 3 wherein the probe is a central nervous system probe.
Claim 6
Dependent Claim
12 words
The catheter of claim 1 wherein the catheter body defines a lumen.
Claim 7
Dependent Claim
47 words
The catheter of claim 1 wherein the at least a portion of the catheter body is fabricated from a polymer selected from the group comprising: a polyethylene terephthalate, a polyethylene, a polyamide, a polyester, a polyolefin, a polypropylene, a polyurethane, a polystyrene, a polysulfone, and a latex.
Claim 8
Dependent Claim
21 words
The catheter of claim 6 wherein the polymer from which the catheter body is fabricated defines the surface of the catheter.
Claim 9
Dependent Claim
21 words
The catheter of claim 7 wherein the polymer defining the surface of the catheter is derivatized to form the substrate layer.
Claim 10
Dependent Claim
32 words
The catheter of claim 1 wherein the substrate layer has an exposed functional group selected from the group comprising: a carboxyl, an amine, an hydroxyl, a sulfhydryl, a succinimide, and a maleimide.
Claim 11
Dependent Claim
27 words
The catheter of claim 1 further comprising: a molecular lattice, said molecular lattice being disposed between and chemically bonded to the substrate layer and the therapeutic agent.
Claim 12
Dependent Claim
40 words
The catheter of claim 10 wherein the molecular lattice includes at least one branched chain, a bond to the substrate layer, and a plurality of bonding sites to which a plurality of molecules of the therapeutic agent are selectively bonded.
Claim 13
Dependent Claim
42 words
The catheter of claim 10 wherein the molecular lattice is a branched polyamino acid including a plurality of amino acids, said amino acids being selected from a group comprising: a lysine, a cysteine, a glutamic acid, an alanine, and an aspartic alanine.
Claim 14
Dependent Claim
21 words
The catheter of claim 10 wherein an ancillary compound is bonded to the molecular lattice in addition to the therapeutic agent.
Claim 15
Dependent Claim
14 words
The catheter of claim 13 wherein the ancillary compound is a fluorescent marker compound.
Claim 16
Dependent Claim
15 words
The catheter of claim 1 wherein the linker layer is formed from a heterobifunctional agent.
Claim 17
Dependent Claim
16 words
The catheter of claim 15 wherein the heterobifunctional agent is covalently bonded to the therapeutic agent.
Claim 18
Dependent Claim
17 words
The catheter of claim 15 wherein the linker layer is formed from a 2 nitro benzyl compound.
Claim 19
Dependent Claim
72 words
The catheter of claim 15 wherein the substrate layer has an exposed functional group, the heterobifunctional agent being bonded to said exposed functional group, the heterobifunctional agent further including an aromatic ring having a nitro group, said nitro group being disposed in an ortho position relative to a methyl group or an ethyl group, said methyl group or said ethyl group being functionalized to accept a complementary bond to the therapeutic agent.
Claim 20
Dependent Claim
54 words
The catheter of claim 18 wherein the methyl group or the ethyl group are selected from the group comprising: a methyl, an ethyl, an amino methyl, a 1-amino ethyl, a bromo methyl, a 1-bromo ethyl, a methyl hydrazone, a methyl hydrazine, a 1-ethyl hydrazone, a 1-ethyl hydrazine, a chlorocarbonyl methyl, and a 1-chlorocarbonyl ethyl.
Claim 21
Dependent Claim
67 words
The catheter of claim 15 wherein the linker layer is formed from a 2-nitro phenyl compound including an aromatic ring having an ortho position, a meta position, and a para position, a nitro phenyl group being disposed in said ortho position, said 2 nitro phenyl group having a first functionality, said 2-nitro phenyl compound having a second functionality disposed at said meta position or said para position.
Claim 22
Dependent Claim
40 words
The catheter of claim 1 wherein the therapeutic agent is selected from a group comprising: a peptide, a protein, a carbohydrate, asteroid, a lipid, a nucleotide, an antisense nucleotide, a peptide fragment, a nucleotide fragment, and an antisense nucleotide fragment.
Claim 23
Dependent Claim
13 words
The catheter of claim 1 wherein the therapeutic agent is an antisense oligodeoxynucleotide.
Claim 24
Dependent Claim
15 words
The catheter of claim 1 wherein the therapeutic agent is a peptide fragment hirudin (54-65).
Claim 25
Independent Claim
126 words
A method for applying a therapeutic agent to a tissue site, said method comprising the steps of: providing a catheter having a catheter body and a surface including a substrate layer; connecting a linker layer and the therapeutic agent to said substrate layer, said linker layer being chemically bonded to said substrate layer, the therapeutic agent being chemically bonded to said linker layer; positioning at least a portion of said catheter body to which the therapeutic agent connected generally proximate to the remotely located tissue site; and applying light energy to said substrate layer or said linker layer such that the therapeutic agent is selectively and responsively released from said substrate layer by a photolyric chemical reaction occurring in response to exposure to said light energy.
Claim 26
Independent Claim
126 words
A method for applying a therapeutic agent to a tissue site, said method comprising the steps of: providing a catheter having a catheter body and a surface including a substrate layer; connecting a linker layer and the therapeutic agent to said substrate layer, said linker layer being chemically bonded to said substrate layer, the therapeutic agent being chemically bonded to said linker layer; positioning at least a portion of said catheter body to which the therapeutic agent connected generally proximate to the remotely located tissue site; and applying light energy to said substrate layer or said linker layer such that the therapeutic agent is selectively and responsively released from said substrate layer by a photolyric chemical reaction occurring in response to exposure to said light energy.
References Cited (Backward Citations)
US2883986A
Cited
US3435826A
Cited
US3467101A
Cited
US3570476A
Cited
US3901829A
Cited
US4062746A
Cited
US4156066A
Cited
US4156067A
Cited
US4195637A
Cited
US4359453A
Cited
US4323071B1
Cited
US4323071A
Cited
US4289128A
Cited
US4271839A
Cited
US4573966A
Cited
US4545390A
Cited
US4479497A
Cited
US4581017A
Cited
US4581017B1
Cited
US4554929A
Cited
US4531943A
Cited
US4582181A
Cited
US4571240A
Cited
US4702252A
Cited
US4771130A
Cited
US4597755A
Cited
US4610241A
Cited
US4799479A
Cited
US4762129B1
Cited
US4762129A
Cited
US4616648A
Cited
US4824436A
Cited
US5057106A
Cited
US5002531A
Cited
US4846171A
Cited
US5263992A
Cited
US4743673A
Cited
US4835258A
Cited
US4748982A
Cited
US5163898A
Cited
US4807620A
Cited
US4957481A
Cited
US4878492A
Cited
US4940055A
Cited
US5086068A
Cited
US5026367A
Cited
US4895560A
Cited
US5126140A
Cited
US5100429A
Cited
US4994033A
Cited
US5061273A
Cited
US5032666A
Cited
US4976690A
Cited
US5106386A
Cited
US4997431A
Cited
US5109859A
Cited
US5009659A
Cited
US5047025A
Cited
US5087256A
Cited
US5171264A
Cited
US5092841A
Cited
US5199951A
Cited
US5120322A
Cited
US5207670A
Cited
US5236410A
Cited
US5217482A
Cited
US5156594A
Cited
US5053033A
Cited
US5102402A
Cited
US5171217A
Cited
US5232446A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1998-11-27 | 1999-05-29 | 1999-11-28 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2002-11-27 | 2003-05-29 | 2003-11-28 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2006-11-27 | 2007-05-29 | 2007-11-28 | $7700.00 | Window Closed / Lapsed |